“We see more good than bad happening in 2025 and believe this will cause Softline’s’ valuation gap vs the S&P 500 to narrow, ...

Is IBM's software business growth underestimated due to AI expansion? Its P/E ratio has increased significantly, impacting the return/risk ratio. Learn more on IBM stock here.

NuScale's regulatory approval for SMRs in the U.S. gives it a unique market position, with a major project to go live in 2029 ...

Sanofi’s Dupixent and new drugs drive growth, despite near-term pressures. See why SFY stock’s product pipeline makes it a ...

US job growth surged in December, surpassing expectations. The services sector drove gains, but wage growth slightly slowed.

Beta Bionics is commercializing innovative insulin delivery technologies, but faces challenges in achieving profitability.

Solana's advancements in scalability, security, and developer growth make it a strong long-term hold, despite potential short ...

Microsoft’s focus on long-term AI success explains recent stock behavior. See why MSFT stock, with recent reallocations, is ...

The Hershey Company is a strong hold, but Mondelez offers growth potential. See why HSY and MDLZ stocks could offer better ...

BioCryst ( NASDAQ: BCRX) released its preliminary 2024 revenue results, along with guidance for 2025. The company said it ...

Inflation risk is topical again. As a result, the bond market is demanding a higher yield premium to compensate for the possibility that inflation will be higher than recently expected.

Starbucks' premium valuation is harder to justify amid declining performance. Find out why SBUX stock may face more downside, ...